Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1982 1
1986 3
1987 1
1988 1
1992 2
1993 2
1994 3
1995 2
1996 2
1997 1
1999 1
2000 2
2001 2
2002 3
2003 2
2004 3
2005 4
2006 2
2007 1
2008 4
2009 2
2010 1
2011 3
2012 2
2013 4
2014 6
2015 2
2016 5
2017 3
2018 6
2019 5
2020 4
2021 0
Text availability
Article attribute
Article type
Publication date

PubMed Links for id: 20210

77 results
Results by year
Filters applied: . Clear all
Page 1
The serum amyloid A3 promoter-driven luciferase reporter mice is a valuable tool to image early renal fibrosis development and shows the therapeutic effect of glucosyl-hesperidin treatment.
Kumrungsee T, Kariya T, Hashimoto K, Koyano T, Yazawa N, Hashimoto T, Sanada Y, Matsuyama M, Sotomaru Y, Sakurai H, van de Loo FAJ, Yanaka N. Kumrungsee T, et al. Sci Rep. 2019 Oct 1;9(1):14101. doi: 10.1038/s41598-019-50685-0. Sci Rep. 2019. PMID: 31575974 Free PMC article.
Serum amyloid A3 is pro-atherogenic.
Thompson JC, Wilson PG, Shridas P, Ji A, de Beer M, de Beer FC, Webb NR, Tannock LR. Thompson JC, et al. Atherosclerosis. 2018 Jan;268:32-35. doi: 10.1016/j.atherosclerosis.2017.11.011. Epub 2017 Nov 17. Atherosclerosis. 2018. PMID: 29175652 Free PMC article.
77 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page